Interventions to Decrease Unplanned Healthcare Utilization and Improve Quality of Care in Adults With Inflammatory Bowel Disease: A Systematic Review
Author:
Funder
Takeda Pharmaceutical Company
Pfizer
AbbVie
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference74 articles.
1. Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn’s disease;Singh;Aliment Pharmacol Ther,2018
2. First- and second-line pharmacotherapies for patients with moderate to severely active ulcerative colitis: an updated network meta-analysis;Singh;Clin Gastroenterol Hepatol,2020
3. Contemporary risk of surgery in patients with ulcerative colitis and Crohn’s disease: a meta-analysis of population-based cohorts;Tsai;Clin Gastroenterol Hepatol,2020
4. Gastroenterologists’ attitudes and self-reported practices regarding inflammatory bowel disease;Altschuler;Inflamm Bowel Dis,2008
5. Does it matter where you are hospitalized for inflammatory bowel disease? a nationwide analysis of hospital volume;Ananthakrishnan;Am J Gastroenterol,2008
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Monitoring Postoperative Crohn’s Disease—Closing the Gap;Digestive Diseases and Sciences;2023-08-07
2. Transition-of-care program from emergency department to gastroenterology clinics improves follow-up;The American Journal of Emergency Medicine;2023-07
3. Automated Clinical Pathway Utilizing Custom Risk Stratification Identifies Substantial Rates of Overdue Follow-up Among Patients With Inflammatory Bowel Disease and Facilitates Population Health Interventions;Inflammatory Bowel Diseases;2023-03-02
4. Polysubstance use in inflammatory bowel disease is associated with increased risk of emergency department visits: a longitudinal study;Annals of Gastroenterology;2023
5. Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education;Intestinal Research;2022-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3